María Covadonga Martínez Díaz Caneja-rekin lankidetzan egindako argitalpenak (25)

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry

  2. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?

    European Child and Adolescent Psychiatry, Vol. 33, Núm. 3, pp. 799-810

  3. The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysis

    European Psychiatry

2023

  1. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

    Psychiatry Research, Vol. 325

  2. Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy

    Scientific Reports, Vol. 13, Núm. 1

  3. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

2022

  1. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 243, pp. 32-42

  2. Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

    Schizophrenia, Vol. 8, Núm. 1

  3. Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia

    Nature Communications, Vol. 13, Núm. 1

  4. The effect of early life events on glucose levels in first-episode psychosis

    Frontiers in Endocrinology, Vol. 13

2021

  1. Exploring risk and resilient profiles for functional impairment and baseline predictors in a 2-year follow-up first-episode psychosis cohort using latent class growth analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 1, pp. 1-20

  2. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

    European Neuropsychopharmacology, Vol. 47, pp. 112-129

  3. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis

    EClinicalMedicine, Vol. 36

  4. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

2020

  1. Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period

    Journal of Psychopharmacology, Vol. 34, Núm. 5, pp. 514-523

  2. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  3. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2018

  1. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis

    Schizophrenia Research, Vol. 193, pp. 188-196

  2. Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis

    Journal of Psychopharmacology, Vol. 32, Núm. 6, pp. 702-710

  3. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256